Insider Transactions in Q1 2025 at Apogee Therapeutics, Inc. (APGE)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 05
2025
|
Michael Thomas Henderson Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
15,000
-1.14%
|
$600,000
$40.58 P/Share
|
|
Feb 05
2025
|
Carl Dambkowski Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,520
-1.37%
|
$140,800
$40.69 P/Share
|
|
Feb 05
2025
|
Carl Dambkowski Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
795
+0.31%
|
$17,490
$22.86 P/Share
|
|
Jan 31
2025
|
Michael Thomas Henderson Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,500
+0.64%
|
$187,000
$22.86 P/Share
|
|
Jan 08
2025
|
Michael Thomas Henderson Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
15,000
-0.57%
|
$735,000
$49.05 P/Share
|
|
Jan 02
2025
|
Carl Dambkowski Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
4,085
-0.53%
|
$191,995
$47.18 P/Share
|
|
Jan 02
2025
|
Carl Dambkowski Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,360
+0.52%
|
$29,920
$22.86 P/Share
|